Latest News about AGIO
Recent news which mentions AGIO
From Benzinga
Stocks That Hit 52-Week Lows On Friday
May 27, 2022
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
What 4 Analyst Ratings Have To Say About Agios Pharmaceuticals
February 22, 2022
Tickers
AGIO
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
From Benzinga
FDA Approves Agios' Mitapivat As First Disease-Modifying Therapy For Genetic Blood Disorder
February 18, 2022
Tickers
AGIO
From Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
From Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
From InvestorPlace
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
From Benzinga
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
February 01, 2022
From Benzinga
Agios Presents Mitapivat Long-Term Data On Hemoglobin Response, Transfusion Burden
December 14, 2021
Tickers
AGIO
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021
December 03, 2021
From Benzinga
This Company Says It's One Step Closer to Transforming Cancer Treatment with its Latest Groundbreaking Immunotherapy
November 11, 2021
From Benzinga
Agios Pharmaceuticals, inc (AGIO) Q3 2021 Earnings Call Transcript
November 03, 2021
Tickers
AGIO
From Motley Fool
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
7 Best Biotech Stocks to Buy in 2021 with Huge Upside
August 25, 2021
From InvestorPlace
From Benzinga
Agios' Rare Anemia Drug Application Under FDA Priority Review
August 18, 2021
Tickers
AGIO
From Benzinga
From Benzinga
Tickers
AGIO
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.